FDA granted CMG901 Fast Track Designation for unresectable or metastatic gastric and gastroesophageal junction cancer which have relapsed and/or are refractory to approved therapies ...Middle East

CHENGDU, China, April 19, 2022 /PRNewswire/ -- Keymed Biosciences (2162.HK) announced that the U.S. Food and Drug Administration (FDA) granted CMG901 Fast Track Designation as monotherapy for the treatment of unresectable or metastatic gastric and gastroesophageal junction cancer which...

Hence then, the article about fda granted cmg901 fast track designation for unresectable or metastatic gastric and gastroesophageal junction cancer which have relapsed and or are refractory to approved therapies was published today ( Wednesday 20/04/2022 - 05:43 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA granted CMG901 Fast Track Designation for unresectable or metastatic gastric and gastroesophageal junction cancer which have relapsed and/or are refractory to approved therapies )

Also on site :

• Inflatable Tanning Pool Loungers Are Going Viral, and Amazon’s ‘Super Comfy’ $28 Version Is a Shopper Favorite
• Quote of the Day: French Novelist Marcel Proust on Gratitude and the People Who Make Our Souls Blossom
• Valmet delivers board making line and lifecycle support to Sun Paper in China, enabling energy- and resource-efficient production